Results 11 to 20 of about 5,669 (183)

Stereotactic arrhythmia radioablation for refractory ventricular tachycardia: A narrative review and pooled analysis of clinical outcomes and treatment delivery approaches. [PDF]

J Appl Clin Med Phys
Abstract Purpose Stereotactic arrhythmia radioablation (STAR) has emerged as a noninvasive salvage therapy for refractory ventricular tachycardia (VT), particularly in patients ineligible for catheter ablation (CA). This narrative review and pooled analysis evaluates STAR's efficacy, safety, and technical characteristics, integrating evidence from ...
Shah KD, Chang CW, Tian S, Patel P, Qiu R, Momin S, Roper J, Zhou J, Tian Z, Yang X.   +9 more
europepmc   +2 more sources

Assessment of rotational dose perturbations in SBRT: A radiomic-dosiomic predictive model based on the structural similarity index measure. [PDF]

J Appl Clin Med Phys
Abstract Background Stereotactic body radiation therapy (SBRT) delivers ablative doses with high precision but is sensitive to target motion, especially rotational errors. Conventional dose metrics (dose difference (DD), distance‐to‐agreement (DTA), gamma index) show limited sensitivity.
Qi R, Sun J, Mu T, Shi H, Zhang J, Dai X.   +5 more
europepmc   +2 more sources

SBRT for the Primary Treatment of Localized Prostate Cancer: The Effect of Gleason Score, Dose and Heterogeneity of Intermediate risk on Outcome Utilizing 2.2014 NCCN Risk Stratification Guidelines

Frontiers in Oncology, 2014
Purpose: To report an update of our previous experience using stereotactic body radiation therapy (SBRT) for the primary treatment of prostate cancer, risk stratified by the updated NCCN version 2.2014, reporting efficacy and toxicity in a community ...
Matthew eBernetich, Matthew eBernetich, Caspian eOliai, Rachelle eLanciano, Rachelle eLanciano, Rachelle eLanciano, Alexandra eHanlon, John eLamond, John eLamond, Stephen eArrigo, Stephen eArrigo, Jun eYang, Jun eYang, Michael eGood, Jing eFeng, Royce eBrown, Bruce eGarber, Michael eMooreville, Luther W. Brady, Luther W. Brady   +19 more
doaj   +1 more source

Survival and control prognosticators of recurrent gynecological malignancies of the pelvis and para-aortic region treated with stereotactic body radiation therapy (SBRT)

Frontiers in Oncology, 2016
: Purpose: To define prognostic factors associated with improved survival and local control for gynecologic cancer recurrences limited to the pelvis and para-aortic region using stereotactic body radiation therapy (SBRT).Methods: Between 2/2008 and 7 ...
Shaakir Hasan, Anthony Ricco, Kaylette Jenkins, Rachelle Lanciano, Alexandra Hanlon, John Lamond, Jun Yang, Jing Feng, Michael Good, Joel Noumoff, Luther Brady   +10 more
doaj   +1 more source

Salvage fractionated Stereotactic Radiotherapy (fSRT) with or without chemotherapy and immunotherapy for recurrent Glioblastoma Multiforme: A single institution experience

Frontiers in Oncology, 2015
Background: The current standard of care for salvage treatment of Glioblastoma Multiforme (GBM) is gross total resection and adjuvant chemoradiation for operable patients.
Shaakir eHasan, Eda eChen, Rachelle eLanciano, Rachelle eLanciano, Jun eYang, Jun eYang, Alex eHanlon, Alex eHanlon, John eLamond, John eLamond, Stephen eArrigo, Stephen eArrigo, William eDing, William eDing, Michael eMikhail, Arezoo eGhaneie, Luther eBrady, Luther eBrady   +17 more
doaj   +1 more source

The Comparison of Stereotactic Body Radiation Therapy (SBRT) andIntensity Modulated Radiation Therapy (IMRT) for prostate cancer byNCCN risk groups

Frontiers in Oncology, 2016
OBJECTIVES: The primary objective of this study is to compare freedom from biochemical failure (FFBF) between SBRT and IMRT for patients with organ confined prostate cancer treated between 2007 through 2012 utilizing the 2015 National Comprehensive ...
Anthony Ricco, Genevieve Manahan, Genevieve Manahan, Rachelle Lanciano, Rachelle Lanciano, Alexandra Hanlon, Jun Yang, Jun Yang, Stephen Arrigo, John Lamond, John Lamond, Jing Feng, Michael Mooreville, Bruce Garber, Luther Brady, Luther Brady   +15 more
doaj   +1 more source

Stereotactic body radiation therapy for prostate cancer: a study comparing 3-year genitourinary toxicity between CyberKnife and volumetric-modulated arc therapy by propensity score analysis

Radiation Oncology, 2023
Background To investigate whether the rate of stereotactic body radiation therapy-related (SBRT-related) genitourinary (GU) toxicity is lower in patients with prostate cancer treated with CyberKnife.
Makoto Ito, Yasuo Yoshioka, Yuuki Takase, Junji Suzuki, Hironori Takahashi, Yoshitaka Minami, Ami Sakuragi, Yukihiko Oshima, Takahito Okuda, Kojiro Suzuki   +9 more
doaj   +1 more source

SBRT: An opportunity to improve quality of life for oligometastatic prostate cancer?

Frontiers in Oncology, 2015
Objective: Oligometastatic prostate cancer is a limited metastatic disease state in which potential long-term control is still possible with the use of targeted therapies such as surgery or stereotactic body radiation therapy (SBRT).
Gregory eAzzam, Rachelle eLanciano, Rachelle eLanciano, Steve eArrigo, Steve eArrigo, John eLamond, John eLamond, Billy eDing, Jun eYang, Jun eYang, Alexandra eHanlon, Michael eGood, Luther eBrady, Luther eBrady   +13 more
doaj   +1 more source

Cyberknife Radiosurgery for Trigeminal Neuralgia [PDF]

Stereotactic and Functional Neurosurgery, 2003
<i>Background:</i> We present preliminary results using Cyberknife radiosurgery as a noninvasive treatment for trigeminal neuralgia (TN). <i>Methods:</i> Ten patients with medically refractory TN who were deemed unsuitable for conventional surgery underwent Cyberknife radiosurgery using CT cisternography for localization.
Pantaleo, Romanelli, Gary, Heit, Steven D, Chang, Dave, Martin, Christopher, Pham, John, Adler   +5 more
openaire   +2 more sources

Influence of Specific Treatment Parameters on Nontarget and Out-of-Field Doses in a Phantom Model of Prostate SBRT with CyberKnife and TrueBeam

Life, 2022
The aim of the study was to determine the influence of a key treatment plan and beam parameters on overall dose distribution and on doses in organs laying in further distance from the target during prostate SBRT.
Marta Kruszyna-Mochalska, Agnieszka Skrobala, Piotr Romanski, Adam Ryczkowski, Wiktoria Suchorska, Katarzyna Kulcenty, Igor Piotrowski, Dorota Borowicz, Kinga Graczyk, Natalia Matuszak, Julian Malicki   +10 more
doaj   +1 more source